Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DPR000126

Drug Information
NameRemacemide
SynonymsPR1032-646; CHEMBL25843; 2-amino-N-(1-methyl-1,2-diphenylethyl)acetamide; Remacemida; (+-)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide; PR 934-423; LS-8058; FPL 12924AA; REMACEMIDE; C067553; LS-8059; FPL 12924; FPL 14144; 118754-12-4; FPL 14145; Remacemida [INN-Spanish]; Acetamide, 2-amino-N-(1-methyl-1,2-diphenylethyl)-, (+)-; BRD-A36074203-003-03-5; 128298-28-2; CID60511; PR-934-423; FPL-12944AA; Acetamide, 2-amino-N-(1-methyl-1,2-diphenylethyl)-, (-)-; Remacemidum; AC1L1TE2; PR 1032-644; remacemide monohydrochloride, (+-)-isomer; MolPort-002-546-231; Remacemide [INN]; (-)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide; Acetamide, 2-amino-N-(1-methyl-1,2-diphenylethyl)-, (+-)-; (+)-2-Amino-N-(1-methyl-1,2-diphenylethyl)acetamide; 118754-14-6; C17H20N2O; Remacemidum [INN-Latin]; 2-amino-N-(1,2-diphenylpropan-2-yl)acetamide; LS-8057
CompanyAstra Zeneca
IndicationHuntingtonĄ¯s disease
[ICD9: 294.1, 333.4   ICD10: F02.2, G10]
Discontinued in Phase III    
Parkinson's DiseaseDiscontinued in Phase I    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H20N2O/c1-17(19-16(20)13-18,15-10-6-3-7-11-15)12-14-8-4-2-5
-9-14/h2-11H,12-13,18H2,1H3,(H,19,20)
InChIKeyYSGASDXSLKIKOD-UHFFFAOYSA-N
Canonical SMILESCC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN    
CAS NumberCAS 128298-28-2
PubChem Compound IDCID 60511.
PubChem Substance IDSID 667990.
TargetNMDA receptorAgonist[1][2]
NMDA receptorAgonist[3][1]
Ref 1Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. To Reference
Ref 2Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep. 2003 Jan;3(1):9-20. To Reference
Ref 3Emerging drug therapies in Huntington's disease. Expert Opin Emerg Drugs. 2009 Jun;14(2):273-97. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543